AdvanCell

AdvanCell is a Sydney-based radiopharmaceutical and biotechnology company. It has raised $439.4M across 3 funding rounds, most recently a $315M Series D in 2026, from investors including T. Rowe Price, Abingworth and SV Health Investors.

Key facts

Open roles at AdvanCell

  1. Director, Clinical-Translational ScienceBrisbane, QLD, Australia
  2. Director, CMC – Precursor Development & ManufacturingBoston, MA
  3. Director, CMC – Radiopharmaceutical Process DevelopmentBoston, MA
  4. Associate Director, CMC – Analytical DevelopmentBoston, MA
  5. Associate Director, Trial Operations & BudgetBoston, MA
  6. Site Head and VP, ManufacturingRichlands, Brisbane, QLD, AU
  7. Director of FacilitiesRichlands, Brisbane, QLD, AU
  8. Director of Supply Chain and LogisticsRichlands, Brisbane, QLD, AU
  9. Director of Radiochemical SeparationsRichlands, Brisbane, QLD, AU

Browse AdvanCell roles by location: Boston, United States · Australia

Land a role at AdvanCell

publicOpen roles & company overview

Every live role, the locations AdvanCell hires across, and the company facts — all above.

membersAlerts & tailored applications

An email the day AdvanCell posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.

Get started

Email & phone for AdvanCell are shown to signed-in members. Sign in →